Social Economic Status and Diabetes Mellitus
Evidence-Based Practice can be defined as the systems, procedures, and processes that are applied in implementing quality research findings on decision making in the clinical setting. However, EBP has been adopted on a limited scope contributing to a significant gap in the best available clinical practices and those implemented in the actual clinical setting. EBP is essential to delivering health services because it eliminates the errors associated with obsolete information, the impact of subjective errors, and clinical practices resulting from unsubstantiated experiences. Due to rapid advances in medical knowledge about advancements in the treatments of Diabetes mellitus patients, suitable change models are required to implement rising changes and improvements in clinical practice. Rogers’ Diffusion of Innovation Model is an appropriate model for implementing desired changes for Diabetes Mellitus patients because it is effective across multiple clinical settings.
The first phase in the implementation of the Rogers Diffusion of Innovation Model is knowledge. In this phase, employees or associated personnel are educated about the functions and mechanisms involved in adopting innovative systems. Persuasion is the second phase, which entails creating individual perceptions about innovations’ attributes about the complexity and relative advantage of specific systems. For instance, in a hospital setting, if nurses perceive a new patient-records management system that a hospital is planning on adopting as complex, they are likely to prefer older systems over new systems (Pashaeypoor et al., 2016). Decision is the third phase of this model. Individuals make the final decisions on whether to dismiss or embrace an innovative system in this phase. The final step involves either adoption or dismissal (Mohammadi et al., 2018). If employees consider innovation as advantageous, they’ll accept its integration into clinical systems. In contrast, if they feel a system to be too expensive or too complicated, the possibilities of dismissing its application are high.
Proposed changes for improving people’s social experiences suffering from diabetes Mellitus in various clinical settings are increasing funding for lower socioeconomic areas, increasing the number of healthcare providers in remote areas, and promoting health services concerning recommended healthy dietary lifestyles (Butler, 2017). These changes will improve access for individuals suffering from diabetes mellitus to essential care in their moments of need. Using Rogers’ Diffusion of Innovation Model will involve five phases. In the first phase, the community and members of the healthcare system will be educated on the proposed solutions’ reasons and benefits.
The second phase will involve persuading people in the community and the healthcare system to participate in implementing these solutions. In the third phase, records will be taken on the willing participants of the model. The final phase is the decision or dismissal. Cooperation will be encouraged between healthcare givers and the community who have accepted the implementation of these solutions. For instance, hospital caregivers will be encouraged to conduct home visits, and the individuals suffering from diabetes mellitus will be asked to consider receiving treatment at home. The decisions of nurses and type 2 patients who chose not to participate in the program will also be respected.
Implementing the Rogers Diffusion of Innovation Model in these proposed solutions to treat diabetes mellitus patients is expected to produce favorable outcomes. For instance, the prevalence of diabetes type 2 in rural areas is expected to reduce due to improved access to nutritional practices, good education on healthcare, and better healthcare access. Reduced type 2 diabetes cases are also expected to decrease due to the efforts to achieve healthcare equity in remote populations (Greenwood et al., 2017). This process’s common barriers include limited training for nurses on providing care to people in remote areas, especially in their homes, and bad time of making consultations from evidence-based research on the most suitable methods of implementing solutions aimed at reducing adverse diabetes mellitus outcomes (Avilés-Santa, 2020). However, appropriate systems will be designed to handle these challenges.
Avilés-Santa, M. L., Monroig-Rivera, A., Soto-Soto, A., & Lindberg, N. M. (2020). Current State of Diabetes Mellitus Prevalence, Awareness, Treatment, and Control in Latin America: Challenges and Innovative Solutions to Improve Health Outcomes Across the Continent. Current diabetes reports, 20(11), 1-44.
Butler, A. M. (2017). Social determinants of health and racial/ethnic disparities in type 2 diabetes in youth. Current diabetes reports, 17(8), 60.
Greenwood, D. A., Gee, P. M., Fatkin, K. J., & Peeples, M. (2017). A systematic review of reviews evaluating technology-enabled diabetes self-management education and support. Journal of diabetes science and technology, 11(5), 1015-1027.
Mohammadi, M. M., Poursaberi, R., & Salahshoor, M. R. (2018). Evaluating the adoption of evidence-based practice using Rogers’s diffusion of innovation theory: a model testing study. Health promotion perspectives, 8(1), 25.
Pashaeypoor, S., Negarandeh, R., & Borumandnia, N. (2016). Factors affecting nurses’ adoption of evidence-based practice based on Rogers’ Diffusion of Innovations Model: A path analysis approach. Journal of hayat, 21(4), 103-112.